載入...
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study
More effective therapeutic strategies are required for patients with poor-prognosis systemic sclerosis (SSc). A phase 2 single-arm study of high-dose immunosuppressive therapy (HDIT) and autologous CD34-selected hematopoietic cell transplantation (HCT) was conducted in 34 patients with diffuse cutan...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
American Society of Hematology
2007
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1939909/ https://ncbi.nlm.nih.gov/pubmed/17452515 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-02-072389 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|